Anxiety Disorders Completed Phase 3 Trials for Fluoxetine (DB00472)

Also known as: Anxiety Disorder / Anxiety NOS

IndicationStatusPhase
DBCOND0027904 (Anxiety Disorders)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00000381Fluoxetine for Anxious ChildrenTreatment